Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
Authors
Keywords
-
Journal
BLOOD
Volume 122, Issue 5, Pages 684-693
Publisher
American Society of Hematology
Online
2013-06-26
DOI
10.1182/blood-2013-02-482513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
- (2011) S. Textor et al. CANCER RESEARCH
- Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6
- (2011) Yili Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells
- (2011) Chia-Wei Chou et al. PLoS One
- Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site
- (2011) M. G. Joyce et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions
- (2010) Mareike Schmudde et al. CANCER LETTERS
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro
- (2010) Lucy Golden-Mason et al. HEPATOLOGY
- NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction
- (2010) Sonja Textor et al. INTERNATIONAL JOURNAL OF CANCER
- Differential Requirement of Histone Acetylase and Deacetylase Activities for IRF5-Mediated Proinflammatory Cytokine Expression
- (2010) D. Feng et al. JOURNAL OF IMMUNOLOGY
- Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes
- (2009) Zhibin Wang et al. CELL
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability
- (2009) M Krishnan et al. ONCOGENE
- HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer
- (2009) A López-Soto et al. ONCOGENE
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started